Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12779/7335
Title: Ceruloplasmin and oxidative stress in severe eosinophilic asthma patients treated with Mepolizumab and Benralizumab
Authors: Landi, C.
Cameli, P.
Vantaggiato, L.
Bergantini, L.
d'Alessandro, M.
Peruzza, M.
Carleo, A.
Shaba, E.
Di Giuseppe, F.
Angelucci, S.
Bargagli, E.
Bini, L.
Keywords: Benralizumab; Mepolizumab; Redox proteomics; Serum; Severe eosinophilic asthma
Issue Date: 2021
Project: None 
Journal: BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
Description: 
224522
URI: http://hdl.handle.net/20.500.12779/7335
ISSN: 1570-9639
DOI: 10.1016/j.bbapap.2020.140563
Appears in Collections:Publications

Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.